WebMay 24, 2024 · (2024-05-24) Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19 Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. WebThis copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Did you know?
WebMay 24, 2024 · SAN DIEGO, May 24, 2024 /PRNewswire/ -- Stemedica Cell Technologies, Inc. ("Stemedica"), a San Diego-based biotech company specializing in the man... WebSafety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging (clinicaltrials.gov) - P1/2 N=29 Active, not recruiting Sponsor: Stemedica Cell Technologies, Inc. Suspended --> Active, not recruiting Trial completion date: Dec 2024 --> Dec 2024 Trial primary completion date: Apr 2024 --> Apr 2024
WebOct 20, 2024 · Pulthera, LLC has received notice from the U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) that it can proceed with "A Phase 2b, Multi-center,... WebMay 24, 2024 · Stemedica Cell Technologies, Inc., a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announced today that it has …
WebMay 24, 2024 · Stemedica Cell Technologies, Inc., a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announced that it has signed … WebMay 24, 2024 · (2024-05-24) Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19 Stockhouse.com uses …
WebMay 24, 2024 · Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
WebMay 24, 2024 · SAN DIEGO: SAN DIEGO, May 24, 2024 /PRNewswire/ -- Stemedica Cell Technologies, Inc. ("Stemedica"), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells,... buena vista italy 7/8WebOct 20, 2024 · Pulthera, LLC has received notice from the U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) that it can proceed with “A Phase 2b, Multi-center, Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of Intravenous Allogenic Bone Marrow-derived Mesenchymal Stem Cells in … buena vista inn san luis obispoWebOct 18, 2024 · SONOMA, Calif. – Pulthera, LLC has received notice from the U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) that it can proceed with “A … buena vista jailWebJan 18, 2024 · May 23, 2024. SAN DIEGO, California, May 24, 2024 – Stemedica Cell Technologies, Inc. (“Stemedica”), a San Diego-based biotech company specializing in the … buena vista jaipurWebMay 24, 2024 · SAN DIEGO, May 24, 2024 /PRNewswire/ --Â Stemedica Cell Technologies, Inc. ("Stemedica"), a San Diego-based biotech company specializing in the … buena vista jacksonville ilbuena vista jasper alWebMay 24, 2024 · SAN DIEGO, May 24, 2024 /PRNewswire/ -- Stemedica Cell Technologies, Inc. (Stemedica), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announced today that it has signed a Licensing Agreement with Pulthera, LLC for the rights to use,... buena vista inn \u0026 suites